Cutting-edge science meeting stringent regulation can make scaling difficult. Deliver the pivots and production ramp-ups for a healthier society with QR_.
The MedTech sector is constantly innovating advanced diagnostic and treatment solutions for public and private sector healthcare, as well as having to respond to unexpected public health events that can create enormous, unexpected global demand and opportunity for MedTech solution providers.
However, the combination of cutting-edge science meeting stringent regulation can make commercialisation and scaling difficult. Many such programmes run late and over budget through different critical path items not being ready or misaligned through poor and incomplete specifications. The resulting impacts for MedTech solution providers are huge – escalating programme costs, delayed certification, postponed revenues, contract penalties, reputational damage and lost first-mover market opportunities.
Quick Release brings the enhanced data practices needed to support quicker certification, enhanced supply chain resilience and faster production ramp-ups. We are the best in the world at doing this and will be your expert partner that will bring order to your data and processes and help you deliver your programmes faster, more efficiently and with less risk – enabling you to realise your full potential as a leader in the MedTech solutions market.
Asset inventory management
This project was tasked with establishing a consistent asset management system to support the ‘Growth’ and the strategic value ‘Accountability’ of the customer. Introducing a web portal and a mobile application that could provide a global overview of all relevant assets for the customer with additional information for procurement, finance, and technical services.
The global Covid-19 pandemic of 2020 was a new and bigger challenge than any nation was prepared for. It caused great pressure on the NHS and its capacity to treat severe respiratory diseases. The challenge to build thousands more ventilators in a matter of weeks was set on the 17th March by PM Boris Johnson, and a consortium was formed to support Penlon in delivering a timely solution.
Medical Device and Life Science SMEs
Samuel FletcherConnect on LinkedIn
Business Leader, Innovation Lab
Mara DonoraConnect on LinkedIn
Julia MacFarlaneConnect on LinkedIn
Business Leader, Programme Management